Ureteroscopic lithotripsy as a first line treatment for distal ureteral calculi in patients with a solitary kidney

Volume: 50 Number: 3 September 1, 2011
  • İsen K
  • Utku V
EN TR

Ureteroscopic lithotripsy as a first line treatment for distal ureteral calculi in patients with a solitary kidney

Abstract

Aim: To evaluate the efficacy and safety of ureteroscopic lithotripsy as a first line treatment for distal ureteral calculi in patients with a solitary kidney. Material and Methods: 21 patients who had a solitary kidney with distal ureteral calculi were enrolled in this study. A 8/9.8 Fr Wolf semi-rigid ureteroscope and pneumatic lithotripter were used for the procedures in all patients. Results: Twenty-two procedures were performed on the patients. Successful fragmentation was achieved in 21 (95.4%) procedures. The mean serum creatinine level was 1.8 mg/dl (range 1.0-4.8). The mean stone size was 8.7 mm (range 7-13). The mean operative time was 36.2 minutes (range 26-48). The mean hospitalization time was 3.1 days (range 1-7). The mean time for DJ stent removal was 10.1 days (range 7-21). Severe complications were not observed during the procedures. However, mucosal injury was observed in one patient, migration of stone fragments into the renal pelvis in one, and fever (>38º) in two. No long-term complications were determined in any patient. Conclusion: It appears that ureteroscopic lithotripsy may be considered as a first line treatment for distal ureteral calculi in patients with a solitary kidney.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

İsen K

Utku V

Publication Date

September 1, 2011

Submission Date

September 1, 2011

Acceptance Date

-

Published in Issue

Year 1970 Volume: 50 Number: 3

Vancouver
1.İsen K, Utku V. Soliter böbrekli olgularda üreter alt uç taşı taşı tedavisinde ilk seçenek tedavi olarak üreteroskopi eşliğinde taşkırma. EJM [Internet]. 2011 Sep. 1;50(3):183-6. Available from: https://izlik.org/JA59YW44FS

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.